TipRanks
Go Ultimate55% OFF

Pablo G. Legorreta Insider Profile

11 Followers

Pablo G. Legorreta, CEO & COB, Director at Royalty Pharma, holds 4.91M shares in Royalty Pharma (Ticker: RPRX), holds 22.62M shares in ProKidney (Ticker: PROK), holds 0.00 shares in Epizyme (Ticker: EPZM).

Pablo G. Legorreta's Trading History

RPRX
Royalty Pharma
Aug 07, 2026CEO & COB, DirectorUninformative Buy―$330.00M
PROK
ProKidney
Jun 05, 2025Director, Ten Percent OwnerUninformative Buy―$29.29M
EPZM
Epizyme
Aug 16, 2022―Uninformative Sell―$0.00

You May Also Like

Pablo G. Legorreta insider profile FAQ

What is the percentage of profitable transactions made by Pablo G. Legorreta?
The percentage of profitable transactions made by Pablo G. Legorreta is 0%.
What is the average return per transaction made by Pablo G. Legorreta?
The average return per transaction made by Pablo G. Legorreta is -22.30%.
What stocks does Pablo G. Legorreta hold?
Pablo G. Legorreta holds: RPRX, EPZM, PROK stocks.
What was Pablo G. Legorreta's most profitable transaction?
Pablo G. Legorreta’s most profitable transaction was an Informative Buy of RPRX stock on June 28, 2023. The return on the trade was -8.30%.
What is Pablo G. Legorreta's role in Royalty Pharma?
Pablo G. Legorreta's role in Royalty Pharma is CEO & COB, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.